Eversept Partners, LP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 66 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$470,477
-0.7%
49,008
-29.7%
0.06%
-44.9%
Q1 2020$474,014
-54.4%
69,7080.0%0.12%
-35.5%
Q4 2019$1,038,649
+45.4%
69,7080.0%0.18%
-17.6%
Q3 2019$714,507
-3.3%
69,7080.0%0.22%
+7.2%
Q2 2019$738,905
-24.2%
69,7080.0%0.21%
-27.1%
Q1 2019$974,51869,7080.28%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders